The Concomitant Use of Atorvastatin and Amlodipine Leading to Rhabdomyolysis

被引:6
作者
Khan, Salman [1 ]
Khan, Imran [2 ]
Novak, Matthew [3 ]
Regmi, Asish [1 ]
Difilippo, William [3 ]
机构
[1] Robert Packer Hosp, Guthrie Clin, Internal Med, Sayre, PA 18840 USA
[2] North Shore Univ Hosp, Hofstra North Shore LIJ Sch Med, Dept Cardiol, Manhasset, NY USA
[3] Robert Packer Hosp, Guthrie Clin, Nephrol, Sayre, PA USA
来源
CUREUS | 2018年 / 10卷 / 01期
关键词
statin; calcium channel blockers; rhabdomyolysis; cholesterol; kidney;
D O I
10.7759/cureus.2020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 65-year-old man, with a history of hypertension and hyperlipidemia, presented with intractable lower back pain, shortness of breath, and decreasing urine output at the emergency room and was admitted after he was found to have elevated creatinine kinase levels of greater than 160,000 U/L. We discontinued all his home medications, which included atorvastatin and amlodipine. We trended his creatine phosphokinase (CPK) level daily and noticed it decreasing significantly off these meds. We hydrated him with normal saline and monitored his kidney functions. By the time he was ready for discharge, his CPK levels were back to normal. This case report summarizes the drug-drug interactions of atorvastatin and amlodipine.
引用
收藏
页数:3
相关论文
共 5 条
  • [1] Possible risks to patients receiving statins combined with other medications
    Hansten, PD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (03) : 519 - 520
  • [2] Statin myopathy: a review of recent progress
    Mammen, Andrew L.
    Amato, Anthony A.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (06) : 644 - 650
  • [3] Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin
    Mazzu, AL
    Lasseter, KC
    Shamblen, EC
    Agarwal, V
    Lettieri, J
    Sundaresen, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (04) : 391 - 400
  • [4] Diagnostic evaluation of rhabdomyolysis
    Nance, Jessica R.
    Mammen, Andrew L.
    [J]. MUSCLE & NERVE, 2015, 51 (06) : 793 - 810
  • [5] Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
    Zhou, Yi-Ting
    Yu, Lu-Shan
    Zeng, Su
    Huang, Yu-Wen
    Xu, Hui-Min
    Zhou, Quan
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 17 - 25